NWHN in the News
Women’s health topics attract a lot of media attention — whether it’s new research about menopause, a question about the safety of breast implants or a contraceptive, or a political attack on critical women’s health services. The NWHN is a trusted source for explaining women’s perspectives on these, and many other, health developments.
Click here to view our 2017 media highlights.
Highlights – 2018
July 2018 | Prevention.com cites the NWHN as an organization promoting gender equity in medical research, education, and practice so that women no longer need to be a “super informed patient” in order to get proper medical care.
June 2018 | How Stuff Works cited the NWHN’s research on the controversial “female libido enhancer” known as Addyi.
June 2018 | NWHN’s Cindy Pearson is interviewed about malady mongers and how Big Pharma sells treatments by inventing diseases.
June 2018 | NWHN Executive Director Cindy Pearson is quoted in the New York Times on why prices keep rising for drugs treating painful sex in women.
May 2018 | Ed Silverman of STAT quotes Cindy Pearson, executive director of the National Women’s Health Network in his article detailing the fate of Addyi, a female libido pill, in the U.S.
April 2018 | Stephanie Mencimer details the advocacy groups, including NWHN, that demanded a general investigation of NIAAA’s solicitation of donations from the alcohol industry.
April 2018 | Ed Silverman of STAT mentions NWHN in his discussion of the ‘Pre$cription For Power’ database.
April 2018 | NWHN Executive Director Cindy Pearson is quoted in Kaiser Health News’ landmark piece about the new ‘Pre$cription For Power’ database, which details how much funding certain patient advocacy groups get from the pharmaceutical industry.
March 2018 | Actress and director Melanie Mayron gives NWHN a shout out as one of her favorite charities.
March 2018 | NWHN Executive Director Cindy Pearson is quoted in Mary Chris Jaklevic’s article about medical technology company Hologic’s misleading and problematic promo regarding cervical cancer.
March 2018 | NWHN’s fibroids fact sheets makes an appearance in another story about AbbVie’s recent study about elagolix, a possible treatment for endometriosis and fibroids.
March 2018 | AbbVie, a research-based biopharmaceutical company conducts a study on possible endometriosis and fibroid treatment elagolix, and Equities.com references NWHN’s fibroids fact sheet.
March 2018 | NWHN’s hysterectomy fact sheet gets another shout out from Vogue writer Elizabeth Varnell, who recounts Lena Dunham’s own experience.
The Hamilton Spectator
February 2018 | Liam Stack’s piece about hysterectomies makes another appearance in The Hamilton Spectator, including another shout out for NWHN’s hysterectomy fact sheet.
February 2018 | Women’sHealth.com talks about Lena Dunham’s experience with her hysterectomy, referencing NWHN’s statistics about removal of the uterus or ovaries at a young age.
February 2018 | Another study conducted about elagolix’s effect on fibroids is published by AbbVie, and NWHN’s fibroids fact sheet makes an appearance.
February 2018 | Matt Hoffman of MD Magazine references NWHN’s fact sheets on uterine fibroids in his piece about elagolix, an oral gonadotropin-releasing hormone antagonist being studied for the treatment of endometriosis and uterine fibroids.
February 2018 | NWHN’s fact sheets on hysterectomies get a shout out from New York Times author Liam Stack, who writes about actress Lena Dunham’s experience getting a hysterectomy after enduring endometriosis.
January 2018 | NWHN’s Policy Advocacy Director Sarah Christopherson says crisis pregnancy centers “are designed for one purpose—to make sure everyone carries their pregnancy to full term—and they’ll do or say anything to make sure that happens.”